SEC Filing Summary: Second Sight Medical Products, Inc.
Business Context and Reporting Period
This Form 8-K, dated November 14, 2019, is a current report filed by Second Sight Medical Products, Inc. (trading symbol: EYES). The filing serves to announce the company's financial results for the three-month and nine-month periods ended September 30, 2019. The detailed results are contained in an earnings release attached as Exhibit 99.1.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being located in the attached Exhibit 99.1 (Earnings Release), which is not included in the source text.
Material Changes
No specific material changes versus prior periods are detailed in the body of this Form 8-K. The document solely acts as a notification that the results for the period ended September 30, 2019, have been announced.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information furnished in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. It further notes that this information shall not be deemed incorporated by reference into any other filing unless expressly set forth by specific reference. No specific guidance, outlook, or risk factors are detailed in the provided text.
Investor Verification Checklist
- Verify the specific revenue and net loss figures for the three and nine months ended September 30, 2019, by reviewing Exhibit 99.1.
- Confirm the company's cash position and liquidity runway as detailed in the attached earnings release.
- Review the full text of the earnings release for any updated guidance or material risk factors not summarized in this 8-K.
- Note that the registrant is identified as an emerging growth company.